Literature DB >> 19003239

Telomerase dysfunction and dyskeratosis congenita.

Amanda J Walne1, Inderjeet Dokal.   

Abstract

Dyskeratosis congenita (DC) is a multi system bone marrow failure syndrome characterized by muco-cutaneous abnormalities and an increased predisposition to malignancy. It exhibits considerable clinical and genetic heterogeneity. X-linked recessive, autosomal dominant and autosomal recessive forms of the disease are recognized. The X-linked recessive form is due to mutations in dyskerin, which is a component of both small nucleolar ribonuclear protein particles and the telomerase complex. Autosomal dominant DC is due to mutations in the RNA component of telomerase, TERC. As dyskerin and TERC are both components of the telomerase complex and all patients with DC have short telomeres it appears that the principal pathology in DC relates to telomerase dysfunction. The gene or genes involved in the recessive form of DC remain elusive, though genes whose products are required for telomere maintenance remain strong candidates. The study of DC has highlighted the critical role of telomerase and the consequences, including premature aging and malignancy, of its dysfunction.

Entities:  

Year:  2004        PMID: 19003239      PMCID: PMC3449960          DOI: 10.1007/s10616-004-5121-5

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  59 in total

1.  A role for a novel 'trans-pseudoknot' RNA-RNA interaction in the functional dimerization of human telomerase.

Authors:  Hinh Ly; Lifeng Xu; Melissa A Rivera; Tristram G Parslow; Elizabeth H Blackburn
Journal:  Genes Dev       Date:  2003-05-01       Impact factor: 11.361

2.  Distinct biogenesis pathways for human telomerase RNA and H/ACA small nucleolar RNAs.

Authors:  Dragony Fu; Kathleen Collins
Journal:  Mol Cell       Date:  2003-05       Impact factor: 17.970

Review 3.  When cells get stressed: an integrative view of cellular senescence.

Authors:  Ittai Ben-Porath; Robert A Weinberg
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

4.  Haploinsufficiency of mTR results in defects in telomere elongation.

Authors:  Karen S Hathcock; Michael T Hemann; Kay Keyer Opperman; Margaret A Strong; Carol W Greider; Richard J Hodes
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

5.  Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome.

Authors:  Hiroki Yamaguchi; Gabriela M Baerlocher; Peter M Lansdorp; Stephen J Chanock; Olga Nunez; Elaine Sloand; Neal S Young
Journal:  Blood       Date:  2003-04-03       Impact factor: 22.113

Review 6.  Human telomerase and its regulation.

Authors:  Yu-Sheng Cong; Woodring E Wright; Jerry W Shay
Journal:  Microbiol Mol Biol Rev       Date:  2002-09       Impact factor: 11.056

Review 7.  Dyskeratosis congenita: clinical features and genetic aspects. Report of a family and review of the literature.

Authors:  C Sirinavin; A A Trowbridge
Journal:  J Med Genet       Date:  1975-12       Impact factor: 6.318

8.  Association between aplastic anaemia and mutations in telomerase RNA.

Authors:  Tom Vulliamy; Anna Marrone; Inderjeet Dokal; Philip J Mason
Journal:  Lancet       Date:  2002-06-22       Impact factor: 79.321

9.  Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification.

Authors:  Davide Ruggero; Silvia Grisendi; Francesco Piazza; Eduardo Rego; Francesca Mari; Pulivarthi H Rao; Carlos Cordon-Cardo; Pier Paolo Pandolfi
Journal:  Science       Date:  2003-01-10       Impact factor: 47.728

10.  Identification of a new RNA.RNA interaction site for human telomerase RNA (hTR): structural implications for hTR accumulation and a dyskeratosis congenita point mutation.

Authors:  Xiaojun Ren; Gérald Gavory; Haitao Li; Liming Ying; David Klenerman; Shankar Balasubramanian
Journal:  Nucleic Acids Res       Date:  2003-11-15       Impact factor: 16.971

View more
  1 in total

Review 1.  The genetics and clinical manifestations of telomere biology disorders.

Authors:  Sharon A Savage; Alison A Bertuch
Journal:  Genet Med       Date:  2010-12       Impact factor: 8.822

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.